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Ras is a universal eukaryotic intracellular G-protein inte-
grating extracellular signals from multiple receptor types.
Constitutively activated Ha-Ras was expressed selectively
in neurons of a transgenic mouse model named synRas.
Earlier it was shown that degeneration of motor neurons
was completely prevented after facial nerve lesion in syn-
Ras mice, and degeneration of dopaminergic substantia
nigra neurons, induced by neurotoxins, was greatly atten-
uated.
In order to elucidate the mechanisms of neuroprotection,
proteins obtained from synaptosomes and perisynaptical
mitochondria of murine brains were separated using 2D-
DIGE and identified by MALDI-Tof MS. In synRas derived
brains there were changes of the expression level and/or
post-translational modification of more than 20 proteins.
Most of the altered proteins are involved in energy metab-
olism (oxidative phosphorylation pathway, TCA cycle and
ATP transport) and regulation of synaptic vesicular traf-
ficking processes (release of neurotransmitters and vesicle
recycling). In synRas brain the expression level of voltage-
dependent anion channel 1 (VDAC1, also known as
porin), pore-forming protein of the outer mitochondrial
membrane, was threefold decreased. Reduction in VDAC1
protein levels were previously shown to result in resist-
ance towards insults by the pro-apoptotic bcl2-family pro-
teins. Thus, down-regulation of VDAC1 could explain the
neuroprotective effect of Ras protein.
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